July 10, 2019 Redx sells another asset to keep the lights on The UK biotech gets a big boost from the sale of a pan-Raf inhibitor to Jazz Pharmaceuticals, but Redx’s money worries are far from over.
June 04, 2019 Asco 2019 – KRAS chase heats up with Amgen data Amgen has gone further than anyone before to crack KRAS, but caution is required, as efficacy might ultimately not be as positive as initial data suggest.
